Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO

Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Annals of Allergy, Asthma & Immunology - Volume 119, Issue 6, December 2017, Pages 524-532.e2

Bradley E. MD, Robert S. MD, PhD, Allan T. MD, William W. MD, Benjamin L. MS, Evgeniya N. MS, PhD, Hooman PharmD, MBA, Susan L. MD, Paul G. MD, Noelle M. PhD, Thomas B. MD,